EP1379264A4 - Proteines humaines secretees - Google Patents
Proteines humaines secreteesInfo
- Publication number
- EP1379264A4 EP1379264A4 EP02723499A EP02723499A EP1379264A4 EP 1379264 A4 EP1379264 A4 EP 1379264A4 EP 02723499 A EP02723499 A EP 02723499A EP 02723499 A EP02723499 A EP 02723499A EP 1379264 A4 EP1379264 A4 EP 1379264A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- secreted proteins
- human secreted
- human
- proteins
- secreted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27734001P | 2001-03-21 | 2001-03-21 | |
US277340P | 2001-03-21 | ||
US30617101P | 2001-07-19 | 2001-07-19 | |
US306171P | 2001-07-19 | ||
US33128701P | 2001-11-13 | 2001-11-13 | |
US331287P | 2001-11-13 | ||
PCT/US2002/008276 WO2002076488A1 (fr) | 2001-03-21 | 2002-03-19 | Proteines humaines secretees |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1379264A1 EP1379264A1 (fr) | 2004-01-14 |
EP1379264A4 true EP1379264A4 (fr) | 2009-07-08 |
Family
ID=27402891
Family Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02760994A Withdrawn EP1379132A4 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees humaines |
EP02759068A Withdrawn EP1404702A4 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees humaines |
EP02782476A Withdrawn EP1414845A4 (fr) | 2001-03-21 | 2002-03-19 | Proteines humaines secretees |
EP02749512A Withdrawn EP1381622A2 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees par les humains |
EP02799146A Withdrawn EP1390390A4 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees humaines |
EP02780789A Withdrawn EP1423134A2 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees par l'homme |
EP02723499A Withdrawn EP1379264A4 (fr) | 2001-03-21 | 2002-03-19 | Proteines humaines secretees |
Family Applications Before (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02760994A Withdrawn EP1379132A4 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees humaines |
EP02759068A Withdrawn EP1404702A4 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees humaines |
EP02782476A Withdrawn EP1414845A4 (fr) | 2001-03-21 | 2002-03-19 | Proteines humaines secretees |
EP02749512A Withdrawn EP1381622A2 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees par les humains |
EP02799146A Withdrawn EP1390390A4 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees humaines |
EP02780789A Withdrawn EP1423134A2 (fr) | 2001-03-21 | 2002-03-19 | Proteines secretees par l'homme |
Country Status (4)
Country | Link |
---|---|
EP (7) | EP1379132A4 (fr) |
AU (6) | AU2002320013A1 (fr) |
CA (7) | CA2441840A1 (fr) |
WO (7) | WO2003004622A2 (fr) |
Families Citing this family (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7196164B2 (en) | 1997-07-08 | 2007-03-27 | Human Genome Sciences, Inc. | Secreted protein HHTLF25 |
JP2002513295A (ja) | 1997-07-08 | 2002-05-08 | ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド | 123種類のヒト分泌タンパク質 |
US20060052321A1 (en) | 2002-04-05 | 2006-03-09 | Raitano Arthur B | Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
US20040141975A1 (en) | 1998-06-01 | 2004-07-22 | Raitano Arthur B. | Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
US20030149531A1 (en) | 2000-12-06 | 2003-08-07 | Hubert Rene S. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
PT1086223E (pt) | 1998-06-01 | 2009-11-03 | Agensys Inc | Novos antigénios transmembranares em serpentina expressos em cancros humanos e suas utilizações |
US6833438B1 (en) | 1999-06-01 | 2004-12-21 | Agensys, Inc. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
WO2000042073A1 (fr) | 1999-01-15 | 2000-07-20 | Biogen, Inc. | Antagonistes de la proteine tweak et du recepteur de tweak, et leur utilisation pour traiter des affections immunitaires |
EP1666490A3 (fr) * | 2000-07-25 | 2006-11-02 | Genentech, Inc. | Polypeptides sécrétés et transmembranaires ainsi que les acides nucléiques codant pour ceux-ci |
US7291719B2 (en) | 2000-07-25 | 2007-11-06 | Genentech, Inc. | PRO4332 antibodies |
EP1364021A2 (fr) | 2000-10-31 | 2003-11-26 | Diadexus, Inc. | Compositions et methodes associees a des genes et a des proteines specifiques du colon |
US20020111302A1 (en) * | 2000-11-30 | 2002-08-15 | Y. Tom Tang | Novel nucleic acids and polypeptides |
US7736654B2 (en) * | 2001-04-10 | 2010-06-15 | Agensys, Inc. | Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
US20030119112A1 (en) | 2001-06-20 | 2003-06-26 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
US7494646B2 (en) | 2001-09-06 | 2009-02-24 | Agensys, Inc. | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
ES2532757T3 (es) | 2001-09-06 | 2015-03-31 | Agensys, Inc. | Ácido nucleico y proteína correspondiente denominados STEAP-1 útiles en el tratamiento y la detección de cáncer |
WO2003033727A1 (fr) | 2001-10-12 | 2003-04-24 | Yamanouchi Pharmaceutical Co., Ltd. | Procede de criblage d'un inhibiteur de la mort cellulaire |
CA2887716C (fr) | 2002-04-09 | 2017-01-24 | Biogen Idec Ma Inc. | Procede pour traiter les etats lies a tweak |
AU2003900747A0 (en) * | 2003-02-18 | 2003-03-06 | Garvan Institute Of Medical Research | Diagnosis and treatment of pancreatic cancer |
US7709610B2 (en) | 2003-05-08 | 2010-05-04 | Facet Biotech Corporation | Therapeutic use of anti-CS1 antibodies |
US20050025763A1 (en) | 2003-05-08 | 2005-02-03 | Protein Design Laboratories, Inc. | Therapeutic use of anti-CS1 antibodies |
WO2005019258A2 (fr) * | 2003-08-11 | 2005-03-03 | Genentech, Inc. | Compositions et methodes de traitement de maladies relatives au systeme immunitaire |
EP1670947B1 (fr) | 2003-09-23 | 2015-04-01 | University Of North Carolina At Chapel Hill | Technique et composition de correlation de polymorphisme nucleotidique simple dans le gene vitamine k epoxyde reductase et le dosage de warfarine |
JP4777251B2 (ja) * | 2003-10-14 | 2011-09-21 | バクスター・インターナショナル・インコーポレイテッド | ビタミンkエポキシド還元酵素複合体サブユニット1vkorc1、クマリンおよびその誘導体の治療標的 |
EP1714154A2 (fr) * | 2004-02-03 | 2006-10-25 | Bayer HealthCare AG | Agents diagnostiques et therapeutiques pour des maladies associes a la glutamate carboxypeptidase (pgcp) plasmatique |
US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
AU2004319915B9 (en) | 2004-04-22 | 2011-12-22 | Agensys, Inc. | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
NZ553581A (en) | 2004-09-01 | 2011-04-29 | Dynavax Tech Corp | Methods and compositions for inhibition of innate immune responses and autoimmunity using immunoregulatory polynucleotides with a TGC sequence |
WO2006026808A1 (fr) * | 2004-09-07 | 2006-03-16 | Telethon Institute For Child Health Research | Methode de diagnostic et/ou de prediction du developpement d'une affection allergique |
JP2008512099A (ja) * | 2004-09-07 | 2008-04-24 | テレソン インスティテュート フォー チャイルド ヘルス リサーチ | アレルギー性疾患の処置または予防のための物質 |
AU2006214179A1 (en) | 2005-02-17 | 2006-08-24 | Biogen Idec Ma Inc. | Treating neurological disorders |
CN101124320A (zh) | 2005-02-28 | 2008-02-13 | 巴克斯特国际公司 | 重组共表达维生素k环氧化物还原酶亚基1以提高依赖维生素k的蛋白质表达 |
EP1861499A4 (fr) | 2005-03-15 | 2008-09-03 | Univ North Carolina | Procédés et compositions pour la production de protéines actives dépendantes de la vitamine k |
EP1885388B1 (fr) | 2005-05-10 | 2013-09-11 | Biogen Idec MA Inc. | Traitement et evaluation des troubles inflammatoires |
WO2006138219A2 (fr) | 2005-06-13 | 2006-12-28 | Biogen Idec Ma Inc. | Procedes d'evaluation de patients |
US20090054307A1 (en) * | 2005-09-01 | 2009-02-26 | Howard Florey Institute Of Experimental Physiology And Medicine | Prophylactic and therapeutic agents and uses therefor |
GB0521488D0 (en) * | 2005-10-21 | 2005-11-30 | Ares Trading Sa | Integral membrane protein |
US7572618B2 (en) | 2006-06-30 | 2009-08-11 | Bristol-Myers Squibb Company | Polynucleotides encoding novel PCSK9 variants |
ES2636089T3 (es) | 2006-10-27 | 2017-10-05 | Genentech, Inc. | Anticuerpos e inmunoconjugados y usos para los mismos |
JP5588175B2 (ja) | 2006-11-07 | 2014-09-10 | メルク・シャープ・アンド・ドーム・コーポレーション | Pcsk9のアンタゴニスト |
US8093222B2 (en) | 2006-11-27 | 2012-01-10 | Isis Pharmaceuticals, Inc. | Methods for treating hypercholesterolemia |
CA2680832A1 (fr) * | 2007-03-27 | 2008-10-02 | Merck & Co., Inc. | Procede de detection de pcsk9 secretee, autogeneree |
JOP20080381B1 (ar) | 2007-08-23 | 2023-03-28 | Amgen Inc | بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9) |
JP5749492B2 (ja) | 2007-10-26 | 2015-07-15 | ダイナバックス テクノロジーズ コーポレイション | 免疫応答と自己免疫を阻害する方法及び組成物 |
CA2707182C (fr) * | 2007-11-30 | 2017-12-12 | Siemens Healthcare Diagnostics Inc. | Fragments de recepteur de l'adiponectine et leurs procedes d'utilisation |
AR070316A1 (es) | 2008-02-07 | 2010-03-31 | Merck & Co Inc | Antagonistas de pcsk9 (proproteina subtilisina-kexina tipo 9) |
AR070315A1 (es) | 2008-02-07 | 2010-03-31 | Merck & Co Inc | Anticuerpos 1b20 antagonistas de pcsk9 |
WO2010068526A1 (fr) | 2008-12-12 | 2010-06-17 | Merck Sharp & Dohme Corp. | Immunodosage de pcsk9 |
AU2010313381A1 (en) | 2009-10-30 | 2012-04-12 | Merck Sharp & Dohme Corp. | AX1 and AX189 PCSK9 antagonists and variants |
CN102639150A (zh) | 2009-10-30 | 2012-08-15 | 默沙东公司 | Ax213和ax132 pcsk9拮抗剂和变体 |
BR112012032240A2 (pt) | 2010-06-16 | 2019-09-24 | Dynavax Technologies Corporation | método de tratamento utilizando inibidores tlr7 e/ou tlr9 |
CN105061534A (zh) | 2010-09-22 | 2015-11-18 | 艾丽奥斯生物制药有限公司 | 取代的核苷酸类似物 |
WO2012088222A2 (fr) | 2010-12-21 | 2012-06-28 | The University Of North Carolina At Chapel Hill | Procédés et compositions pour la production de protéines actives dépendantes de la vitamine k |
AU2012358804B2 (en) | 2011-12-22 | 2018-04-19 | Alios Biopharma, Inc. | Substituted phosphorothioate nucleotide analogs |
US8916538B2 (en) | 2012-03-21 | 2014-12-23 | Vertex Pharmaceuticals Incorporated | Solid forms of a thiophosphoramidate nucleotide prodrug |
NZ630805A (en) | 2012-03-22 | 2016-01-29 | Alios Biopharma Inc | Pharmaceutical combinations comprising a thionucleotide analog |
US8945560B1 (en) | 2014-07-15 | 2015-02-03 | Kymab Limited | Method of treating rheumatoid arthritis using antibody to IL6R |
US9045548B1 (en) | 2014-07-15 | 2015-06-02 | Kymab Limited | Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatment |
US8986691B1 (en) | 2014-07-15 | 2015-03-24 | Kymab Limited | Method of treating atopic dermatitis or asthma using antibody to IL4RA |
US9017678B1 (en) | 2014-07-15 | 2015-04-28 | Kymab Limited | Method of treating rheumatoid arthritis using antibody to IL6R |
US8883157B1 (en) | 2013-12-17 | 2014-11-11 | Kymab Limited | Targeting rare human PCSK9 variants for cholesterol treatment |
US9051378B1 (en) | 2014-07-15 | 2015-06-09 | Kymab Limited | Targeting rare human PCSK9 variants for cholesterol treatment |
US8992927B1 (en) | 2014-07-15 | 2015-03-31 | Kymab Limited | Targeting human NAV1.7 variants for treatment of pain |
US9023359B1 (en) | 2014-07-15 | 2015-05-05 | Kymab Limited | Targeting rare human PCSK9 variants for cholesterol treatment |
US9067998B1 (en) | 2014-07-15 | 2015-06-30 | Kymab Limited | Targeting PD-1 variants for treatment of cancer |
US9045545B1 (en) | 2014-07-15 | 2015-06-02 | Kymab Limited | Precision medicine by targeting PD-L1 variants for treatment of cancer |
US9034332B1 (en) | 2014-07-15 | 2015-05-19 | Kymab Limited | Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment |
US9914769B2 (en) | 2014-07-15 | 2018-03-13 | Kymab Limited | Precision medicine for cholesterol treatment |
US8986694B1 (en) | 2014-07-15 | 2015-03-24 | Kymab Limited | Targeting human nav1.7 variants for treatment of pain |
US8980273B1 (en) | 2014-07-15 | 2015-03-17 | Kymab Limited | Method of treating atopic dermatitis or asthma using antibody to IL4RA |
US9682218B2 (en) | 2013-12-23 | 2017-06-20 | Carefusion 2200, Inc. | Pleurodesis device and method |
GB201403775D0 (en) | 2014-03-04 | 2014-04-16 | Kymab Ltd | Antibodies, uses & methods |
US9139648B1 (en) | 2014-07-15 | 2015-09-22 | Kymab Limited | Precision medicine by targeting human NAV1.9 variants for treatment of pain |
US9150660B1 (en) | 2014-07-15 | 2015-10-06 | Kymab Limited | Precision Medicine by targeting human NAV1.8 variants for treatment of pain |
WO2018083248A1 (fr) | 2016-11-03 | 2018-05-11 | Kymab Limited | Anticorps, combinaisons comprenant des anticorps, biomarqueurs, utilisations et procédés |
AU2017382323B2 (en) | 2016-12-23 | 2024-06-13 | President And Fellows Of Harvard College | Gene editing of PCSK9 |
JP7247101B2 (ja) | 2017-04-03 | 2023-03-28 | エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | Steap-1に結合する抗体 |
EP3642383B1 (fr) | 2017-06-22 | 2022-12-21 | The Procter & Gamble Company | Films comprenant une couche hydrosoluble et un revêtement inorganique déposé en phase vapeur |
EP3641951B1 (fr) | 2017-06-22 | 2023-09-20 | The Procter & Gamble Company | Films comprenant une couche hydrosoluble et un revêtement organique déposé en phase vapeur |
WO2021207711A2 (fr) | 2020-04-09 | 2021-10-14 | Verve Therapeutics, Inc. | Arn guides modifiés chimiquement pour l'édition du génome avec cas9 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000004140A1 (fr) * | 1998-07-15 | 2000-01-27 | Human Genome Sciences, Inc. | 71 proteines humaines secretees |
WO2002026931A2 (fr) * | 2000-09-25 | 2002-04-04 | Human Genome Sciences, Inc. | 71 proteines humaines secretees |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100236393B1 (ko) * | 1996-02-02 | 1999-12-15 | 나까니시 히로유끼 | 사람성장호르몬을 함유하는 의약제제 |
US5858716A (en) * | 1997-05-30 | 1999-01-12 | Smithkline Beecham Corporation | H2CAA71 polynucleotides |
-
2002
- 2002-03-19 EP EP02760994A patent/EP1379132A4/fr not_active Withdrawn
- 2002-03-19 WO PCT/US2002/008124 patent/WO2003004622A2/fr not_active Application Discontinuation
- 2002-03-19 WO PCT/US2002/009785 patent/WO2002095010A2/fr not_active Application Discontinuation
- 2002-03-19 CA CA002441840A patent/CA2441840A1/fr not_active Abandoned
- 2002-03-19 EP EP02759068A patent/EP1404702A4/fr not_active Withdrawn
- 2002-03-19 CA CA002441832A patent/CA2441832A1/fr not_active Abandoned
- 2002-03-19 EP EP02782476A patent/EP1414845A4/fr not_active Withdrawn
- 2002-03-19 AU AU2002320013A patent/AU2002320013A1/en not_active Abandoned
- 2002-03-19 CA CA002441397A patent/CA2441397A1/fr not_active Abandoned
- 2002-03-19 AU AU2002354719A patent/AU2002354719A1/en not_active Abandoned
- 2002-03-19 WO PCT/US2002/008276 patent/WO2002076488A1/fr not_active Application Discontinuation
- 2002-03-19 AU AU2002326293A patent/AU2002326293A1/en not_active Abandoned
- 2002-03-19 WO PCT/US2002/008279 patent/WO2002090526A2/fr not_active Application Discontinuation
- 2002-03-19 AU AU2002363296A patent/AU2002363296A1/en not_active Abandoned
- 2002-03-19 AU AU2002332391A patent/AU2002332391A1/en not_active Abandoned
- 2002-03-19 AU AU2002324424A patent/AU2002324424A1/en not_active Abandoned
- 2002-03-19 CA CA002441755A patent/CA2441755A1/fr not_active Abandoned
- 2002-03-19 CA CA002441702A patent/CA2441702A1/fr not_active Abandoned
- 2002-03-19 EP EP02749512A patent/EP1381622A2/fr not_active Withdrawn
- 2002-03-19 EP EP02799146A patent/EP1390390A4/fr not_active Withdrawn
- 2002-03-19 WO PCT/US2002/008123 patent/WO2002102993A2/fr not_active Application Discontinuation
- 2002-03-19 CA CA002441416A patent/CA2441416A1/fr not_active Abandoned
- 2002-03-19 EP EP02780789A patent/EP1423134A2/fr not_active Withdrawn
- 2002-03-19 CA CA002441417A patent/CA2441417A1/fr not_active Abandoned
- 2002-03-19 WO PCT/US2002/008277 patent/WO2003038063A2/fr not_active Application Discontinuation
- 2002-03-19 WO PCT/US2002/008278 patent/WO2002102994A2/fr not_active Application Discontinuation
- 2002-03-19 EP EP02723499A patent/EP1379264A4/fr not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000004140A1 (fr) * | 1998-07-15 | 2000-01-27 | Human Genome Sciences, Inc. | 71 proteines humaines secretees |
WO2002026931A2 (fr) * | 2000-09-25 | 2002-04-04 | Human Genome Sciences, Inc. | 71 proteines humaines secretees |
Non-Patent Citations (3)
Title |
---|
HSU SHEAU YU ET AL: "Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucine-rich repeats and a G protein-coupled, seven-transmembrane region", MOLECULAR ENDOCRINOLOGY, vol. 12, no. 12, December 1998 (1998-12-01), pages 1830 - 1845, XP002528150, ISSN: 0888-8809 * |
LOH E D ET AL: "Molecular Characterization of a Novel Glycoprotein Hormone G-Protein-Coupled Receptor", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 282, no. 3, 6 April 2001 (2001-04-06), pages 757 - 764, XP003002810, ISSN: 0006-291X * |
See also references of WO02076488A1 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1379132A4 (fr) | Proteines secretees humaines | |
EP1408759A4 (fr) | Proteines secretees par les humains | |
EP1251863A4 (fr) | 22 proteines humaines secretees | |
AU2002361452A8 (en) | Secreted proteins | |
GB0218205D0 (en) | Human ZZAP1 protein | |
IL162598A0 (en) | Secreted protein | |
AU2002232596A1 (en) | Secreted human proteins | |
AU2002354803A8 (en) | Secreted proteins | |
EP1368468A4 (fr) | 83 proteines humaines secretes | |
AU2003301843A8 (en) | 157 human secreted proteins | |
EP1385977A4 (fr) | Proteines secretees | |
AU2001294719A1 (en) | Secreted human proteins | |
EP1370651A4 (fr) | 70 proteines humaines secretees | |
EP1417224A4 (fr) | Proteines secretees | |
AU2002365153A1 (en) | 41 human secreted proteins | |
EP1404807A4 (fr) | 20 proteines humaines secretees | |
AU2002246998A1 (en) | 50 human secreted proteins | |
AU2002348034A8 (en) | 16 human secreted proteins | |
AU2002254275A1 (en) | Human secreted proteins | |
AU2002303843A8 (en) | Secreted proteins | |
AU2003211136A8 (en) | 6 human secreted proteins | |
AU2002332483A1 (en) | 13 human secreted proteins | |
AU2002253985A1 (en) | 83 human secreted proteins | |
AU2002247189A1 (en) | 70 human secreted proteins | |
EP1443818A4 (fr) | Proteines secretees et utilisations associees |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20031021 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07H 21/02 20060101ALI20090527BHEP Ipc: C07K 1/00 20060101AFI20090527BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20090605 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20090915 |